The Drug Controller General of India has asked Johnson & Johnson to explain why did it violated statutory provisions and issued advertisements citing a government laboratory test report on its baby powder to say that the product is free of asbestos.
The DGCI issued the show cause notice to the multinational company pointing out that publication of any advertisement on the basis of any test report of a government analyst is not permissible under Section 29 of the of Drugs and Cosmetics Act, 1940.
The drug inspectors earlier on DCGI orders had seized samples of the firm's various baby products from wholesalers, retailers and distributors across the country in December.
The regulator had ordered Johnson and Johnson not to use talc raw material from its Mulund plant in Mumbai and Baddi unit in Himachal Pradesh for production till further directions.
According to a senior Central Drugs Standard Control Organisation (CDSCO) official, the samples of raw materials were tested in Central Drugs Laboratory and were found to be free of asbestos.
The test result was also conveyed to J&J, which used the result to promote its product, he added.
"It has come to the CDSCO's notice that advertisements had been published in various national and regional newspapers recently, inter alia with the heading: 'Your Johnson's baby powder is pure, safe & gentle; Government lab tests confirm Johnson's baby powder is asbestos-free," the notice said.
The notice further pointed out that "publication of any advertisement on the basis of test reports of government analyst is not permissible under Section 29 of the Drugs and Cosmetics Act, 1940."
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
